尽管公布的季度业绩不及预期，托尼克斯制药控股公司（Tonix Pharmaceuticals Holding Co，股票代码：TNXP）周五夜盘仍大涨5.74%，引发市场关注。
根据公司最新发布的财报，截至6月30日的季度调整后每股亏损为3.86美元，高于分析师预期的3.21美元亏损。公司营收为200万美元，同比下降9.5%，也低于分析师预期的243万美元。尽管业绩表现不佳，但投资者似乎对公司的长期前景保持乐观。
值得注意的是，尽管季度业绩不佳，托尼克斯制药的股价本季度已累计上涨71.1%，今年迄今为止更是上涨了86.7%。分析师对该公司保持积极态度，目前平均评级为"买入"，12个月目标价中位数为65.00美元，较上一交易日收盘价61.57美元高出约5.3%。这种乐观情绪可能是推动股价在财报发布后继续上涨的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.